Form 6-K ISRAEL CHEMICALS LTD For: Sep 14

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September, 2017

________________

 

Commission File Number: 001-13742

 

ISRAEL CHEMICALS LTD. 

(Exact name of registrant as specified in its charter)

 

Israel Chemicals Ltd. 

Millennium Tower 

23 Aranha Street 

P.O. Box 20245 

Tel Aviv, 61202 Israel 

(972-3) 684-4400 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X

Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes

No

X

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes

No

X

 

 

 

ISRAEL CHEMICALS LTD.

 

INCORPORATION BY REFERENCE

 

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

ISRAEL CHEMICALS LTD.

 

1.

Results of the Extraordinary General Meeting of Shareholders

 

Item 1

 

Results of the Extraordinary General Meeting of Shareholders

 

Pursuant to the notice of the Extraordinary General Meeting of Shareholders dated August 2, 2017 (reference number 2017-02-066679) and to the Proxy Statement issued by the Company on August 7, 2017 (reference number 2017-02-067909), the Company hereby reports that an Extraordinary General Meeting of Shareholders was held today, September 14, 2017, and approved the Company's engagement in a framework transaction with its parent company, Israel Corporation Ltd. for a period of three years as of September 1, 2017. Upon such approval, the company may enter into a potential joint tier of insurance policy covering its directors and officers liability.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

			Israel Chemicals Ltd.
			By:	/s/ Kobi Altman
				Name:	Kobi Altman
				Title:	Chief Financial Officer

 

 

			Israel Chemicals Ltd.
			By:	/s/ Lisa Haimovitz
				Name:	Lisa Haimovitz
				Title:	Senior Vice President, Global General Counsel and Corporate Secretary

Date: September 14, 2017

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Amendment of the terms concerning Convertible Bonds 2021/1, 2021/2, 2021/3, 2021/4 and 2022/1 issued by Digitalist Group Plc
• Information relating to the total number of voting rights and shares making up the share capital at 26 April 2024 – post blocs acquisition by the Consortium
• Nel ASA: Hy Stor Energy places gigawatt capacity reservation for Mississippi Clean Hydrogen Hub